Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank13
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-35.89M
↓ 39% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-25.78M
Historical baseline
PeriodValueYoY Change
TTM$-35.89M+4.1%
2025$-37.43M+4.4%
2024$-39.14M-20.3%
2023$-32.54M+3.3%
2022$-33.64M-45.5%
2021$-23.13M-31.8%
2020$-17.55M-12.6%
2019$-15.58M-24.3%
2018$-12.54M-20.7%
2017$-10.38M-